Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
Ulrich Hacker, Martin Bentler, Dorota Kaniowska, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1889-1889
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings
Hau Kiu Edna Au, Mark Isalan, Michał Mielcarek
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 206
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Jiang-Hui Wang, Dominic J. Gessler, Wei Zhan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 196
Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets
Maryam Taghdiri, Claudio Mussolino
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7333-7333
Open Access | Times Cited: 27
Advances in Gene Therapy for Rare Diseases: Targeting Functional Haploinsufficiency Through AAV and mRNA Approaches
Nuria Bara-Ledesma, Adrián Viteri-Noël, M. López Rodríguez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 578-578
Open Access | Times Cited: 2
Gene interfered-ferroptosis therapy for cancers
Jinliang Gao, Tao Luo, Jinke Wang
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 84
Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma
Meead Hadi, Omer Qutaiba B. Allela, Mansoureh Jabari, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina
Aurélien Leray, Pierre-Alban Lalys, Juliette Varin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116148-116148
Open Access | Times Cited: 11
Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy
Limor Zwi‐Dantsis, Saira Mohamed, Giulia Massaro, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 239-239
Open Access | Times Cited: 1
Plectin in Cancer: From Biomarker to Therapeutic Target
Samantha M. Perez, Lindsey T. Brinton, Kimberly M. Kelly
Cells (2021) Vol. 10, Iss. 9, pp. 2246-2246
Open Access | Times Cited: 44
Cancer gene therapy goes viral: viral vector platforms come of age
Urban Bezeljak
Radiology and Oncology (2022) Vol. 56, Iss. 1, pp. 1-13
Open Access | Times Cited: 34
AAV-mediated gene therapy: Advancing cardiovascular disease treatment
Huili Zhang, Zhan Qi, Biao Huang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 33
Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Greta Maria Paola Giordano Attianese, Sarah Ash, Melita Irving
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 166-198
Open Access | Times Cited: 17
Process Improvement of Adeno-Associated Virus Production
Jia-Shiung Guan, Kai Chen, Yingnan Si, et al.
Frontiers in Chemical Engineering (2022) Vol. 4
Open Access | Times Cited: 28
Tumor antigen-loaded AAV vaccine drives protective immunity in a melanoma animal model
Karina Krotova, Hisae Kuoch, Colin Caine, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 28, pp. 301-311
Open Access | Times Cited: 16
A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptor
Patrick Reichenbach, Greta Maria Paola Giordano Attianese, Khaoula Ouchen, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 9, pp. 1063-1080
Open Access | Times Cited: 14
Development of Personalized Strategies for Precisely Battling Malignant Melanoma
Armond J. Isaak, G Clements, Rand Gabriel M. Buenaventura, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5023-5023
Open Access | Times Cited: 6
Delivery of mRNA Using Biomimetic Vectors: Progress and Challenges
Menghao Yin, Hanruo Sun, Yanan Li, et al.
Small (2024) Vol. 20, Iss. 43
Closed Access | Times Cited: 5
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Xin Xu, Wenli Chen, Wenjun Zhu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 29
OBSCN restoration via OBSCN-AS1 long-noncoding RNA CRISPR-targeting suppresses metastasis in triple-negative breast cancer
Talia Guardia, Yuqi Zhang, Keyata N. Thompson, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 11
Open Access | Times Cited: 12
Systemic and Local Administration of a Dual-siRNA Complex Efficiently Inhibits Tumor Growth and Bone Invasion in Oral Squamous Cell Carcinoma
Pingchuan Ma, Mingxia He, Haosen Lian, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 661-676
Closed Access | Times Cited: 4
Challenges in Humoral Immune Response to Adeno-Associated Viruses Determination
Daria A. Naumova, Tatyana Krokunova, Denis Maksimov, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 816-816
Open Access
Adeno-associated viral vector targeted evolution for neurofibromatosis gene delivery
Brett Henshey, Ana Carneiro, Kecheng Lei, et al.
Trends in Molecular Medicine (2025)
Closed Access
Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseases
Tomoki Inagaki, Jonna Magdallene Espera, Kang-Hsin Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions
Thomas Böldicke
Antibodies (2022) Vol. 11, Iss. 3, pp. 49-49
Open Access | Times Cited: 15
Cell-targeting Nanomedicine for Bladder Cancer: A Cellular Bioengineering Approach for Precise Drug Delivery
Zakieh Sadat Hoseini, Somayeh Zeinalilathori, Sonia Fathi‐karkan, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106220-106220
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top